The FDA will be announcing a pilot program in 2018 to give a gift to the industry, click link

Innovize was the first company assessed as a proof of concept for this new program through MDIC Case for Quality.

CMMI assessors did a proof of concept review the Innovize Quality System in June 2016 and a second pilot assessment in October 2016.  These assessments provided a structured roadmap to improve the capability of Innovize and provide world class business processes. 

Innovize’s Quality VP, Mark Rutkiewicz has been a key member of the MDIC’s maturity model team and has provided significant input on the development of the Medical Device Maturity Model.